Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00930 |
| Species: | Homo sapiens |
| Position : | chr19:44910240-44910647 |
| Year: | 2026 |
| Title: | A common 19 bp APOE enhancer deletion is protective against Alzheimer's disease in African Americans |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 41629326 |
| MONDO: | |
| Tissue: | Brain |
| Tissue Ontology ID: | UBERON:0000955 |
| Cell Source: | HMC3 microglia cells |
| CVCL ID: | CVCL_II76 |
| Cell Type: | microglial cell |
| Cell Ontology ID: | CL:0000129 |
| Experiment Type: | Enhancer activity assay, TF binding assay |
| High Throughput Method: | |
| Low Throughput Method: | Luciferase reporter assay, RT-RT-qPCR |
| Target gene : | APOC1 |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|